Matches in Nanopublications for { ?s ?p "[Chromosomal translocations that juxtapose the androgen-sensitive transmembrane protease, serine 2 (TMPRSS2) gene promoter to the oncogenic ETS-family transcription factor ERG result in excessive ERG overexpression in approximately 50% of prostate cancer (PCa) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[Chromosomal translocations that juxtapose the androgen-sensitive transmembrane protease, serine 2 (TMPRSS2) gene promoter to the oncogenic ETS-family transcription factor ERG result in excessive ERG overexpression in approximately 50% of prostate cancer (PCa) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Chromosomal translocations that juxtapose the androgen-sensitive transmembrane protease, serine 2 (TMPRSS2) gene promoter to the oncogenic ETS-family transcription factor ERG result in excessive ERG overexpression in approximately 50% of prostate cancer (PCa) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1124639.RAerhFLPXjbedZsqMzGc165Ob_iMOLqRL_cl6RKck92uo130_assertion description "[Chromosomal translocations that juxtapose the androgen-sensitive transmembrane protease, serine 2 (TMPRSS2) gene promoter to the oncogenic ETS-family transcription factor ERG result in excessive ERG overexpression in approximately 50% of prostate cancer (PCa) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124639.RAerhFLPXjbedZsqMzGc165Ob_iMOLqRL_cl6RKck92uo130_provenance.
- NP1124642.RAVf6C7G1tlSsq2584TDB92EcrsWUesfeGXmV-bHZLMGw130_assertion description "[Chromosomal translocations that juxtapose the androgen-sensitive transmembrane protease, serine 2 (TMPRSS2) gene promoter to the oncogenic ETS-family transcription factor ERG result in excessive ERG overexpression in approximately 50% of prostate cancer (PCa) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124642.RAVf6C7G1tlSsq2584TDB92EcrsWUesfeGXmV-bHZLMGw130_provenance.
- NP1124643.RAAw048BwU77l72fqVrKU5Gk8Q2c2b1opRbyb-cEmDpa0130_assertion description "[Chromosomal translocations that juxtapose the androgen-sensitive transmembrane protease, serine 2 (TMPRSS2) gene promoter to the oncogenic ETS-family transcription factor ERG result in excessive ERG overexpression in approximately 50% of prostate cancer (PCa) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124643.RAAw048BwU77l72fqVrKU5Gk8Q2c2b1opRbyb-cEmDpa0130_provenance.
- NP1124644.RACoF7qKOEpG9CnAvM6k9aD1GPtn8MuH45yHp0glGCR4Y130_assertion description "[Chromosomal translocations that juxtapose the androgen-sensitive transmembrane protease, serine 2 (TMPRSS2) gene promoter to the oncogenic ETS-family transcription factor ERG result in excessive ERG overexpression in approximately 50% of prostate cancer (PCa) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124644.RACoF7qKOEpG9CnAvM6k9aD1GPtn8MuH45yHp0glGCR4Y130_provenance.
- NP1124640.RAPZxX6iaZppYuLtNBOB7atc4lQm0mOZM0lwQBxG6tiVY130_assertion description "[Chromosomal translocations that juxtapose the androgen-sensitive transmembrane protease, serine 2 (TMPRSS2) gene promoter to the oncogenic ETS-family transcription factor ERG result in excessive ERG overexpression in approximately 50% of prostate cancer (PCa) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124640.RAPZxX6iaZppYuLtNBOB7atc4lQm0mOZM0lwQBxG6tiVY130_provenance.
- NP1124646.RAMZ_yr582TIykXCXfX0VDyIghvmUnXUeKMdjideLi078130_assertion description "[Chromosomal translocations that juxtapose the androgen-sensitive transmembrane protease, serine 2 (TMPRSS2) gene promoter to the oncogenic ETS-family transcription factor ERG result in excessive ERG overexpression in approximately 50% of prostate cancer (PCa) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124646.RAMZ_yr582TIykXCXfX0VDyIghvmUnXUeKMdjideLi078130_provenance.